Literature DB >> 26663941

First year survival of patients on maintenance dialysis treatment in Poland.

Dorota Brodowska-Kania1, Aleksandra Rymarz1, Krzysztof Gibin Ski1, Julia Kiełczewska1, Jerzy Smoszna1, Marek Saracyn1, Katarzyna Szamotulska2, Stanisław Niemczyk1.   

Abstract

Retrospective analysis of demographic and clinical data of all patients starting dialysis over two years in our Department (n = 105) has been conducted. Factors such as type of dialysis treatment, reason of end-stage renal disease, Body Mass Index (BMI), laboratory tests results, number and cause of death during first year of dialysis were taken under consideration. Five patients have been excluded from the analysis of mortality (four received renal transplantation, one changed dialysis center). Twenty tree deaths have been noted during first year of dialysis treatment. Nine of them occurred during the first three months of therapy. The leading cause of death was cardio-vascular events (n = 14, 60.9%), the second was malignancy (8, 34,8%), one patient died due to catheter associated infection. Malignancy as a cause of end-stage renal disease, lack of outpatient nephrology care, acute mode of beginning renal replacement therapy and lack of erythropoiesis stimulating agents therapy were associated with higher risk of all-cause mortality during first year of dialysis. Being under the outpatient nephrology care, etiology of ESRD other than malignancy and erythropoiesis stimulating agents therapy were independently associated with better survival during this period of time. Other independent variables did not reach statistical significance. To conclude, in order to improve one year survival of dialysis patients, outpatient nephrology care with adequate amount of visits and associated dialysis therapy should be employed.

Entities:  

Keywords:  dialysis; end-stage renal disease; mortality; risk factors

Year:  2015        PMID: 26663941      PMCID: PMC4664594     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  21 in total

Review 1.  The clinical epidemiology of cardiac disease in chronic renal failure.

Authors:  P S Parfrey; R N Foley
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

2.  Obesity and mortality in ESRD: is it good to be fat?

Authors:  R M Hakim; E Lowrie
Journal:  Kidney Int       Date:  1999-04       Impact factor: 10.612

3.  Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study.

Authors:  Vctor Lorenzo; Marisa Martn; Margarita Rufino; Domingo Hernández; Armando Torres; Juan Carlos Ayus
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

4.  Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.

Authors:  Uyen Duong; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Joshua J Zaritsky; Isaac Teitelbaum; Csaba P Kovesdy; Rajnish Mehrotra
Journal:  Am J Nephrol       Date:  2012-01-26       Impact factor: 3.754

5.  Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.

Authors:  David C Wheeler; John N Townend; Martin J Landray
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

Review 6.  Reducing early mortality in hemodialysis patients.

Authors:  Raymond M Hakim
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-11       Impact factor: 2.894

7.  Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20.

Authors:  Kamyar Kalantar-Zadeh; Ouppatham Supasyndh; Robert S Lehn; Charles J McAllister; Joel D Kopple
Journal:  J Ren Nutr       Date:  2003-01       Impact factor: 3.655

8.  Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.

Authors:  Roberto Minutolo; Francesco Lapi; Paolo Chiodini; Monica Simonetti; Elisa Bianchini; Serena Pecchioli; Iacopo Cricelli; Claudio Cricelli; Gaetano Piccinocchi; Giuseppe Conte; Luca De Nicola
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-29       Impact factor: 8.237

9.  Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.

Authors:  Maria Pippias; Vianda S Stel; José Maria Abad Diez; Nikolaos Afentakis; Jose Antonio Herrero-Calvo; Manuel Arias; Natalia Tomilina; Encarnación Bouzas Caamaño; Jadranka Buturovic-Ponikvar; Svjetlana Čala; Fergus J Caskey; Pablo Castro de la Nuez; Harijs Cernevskis; Frederic Collart; Ramón Alonso de la Torre; Maria de Los Ángeles García Bazaga; Johan De Meester; Joan Manuel Díaz; Ljubica Djukanovic; Manuel Ferrer Alamar; Patrik Finne; Liliana Garneata; Eliezer Golan; Raquel González Fernández; Gonzalo Gutiérrez Avila; James Heaf; Andries Hoitsma; Nino Kantaria; Mykola Kolesnyk; Reinhard Kramar; Anneke Kramer; Mathilde Lassalle; Torbjørn Leivestad; Frantisek Lopot; Fernando Macário; Angela Magaz; Eduardo Martín-Escobar; Wendy Metcalfe; Marlies Noordzij; Runolfur Palsson; Ülle Pechter; Karl G Prütz; Marina Ratkovic; Halima Resić; Boleslaw Rutkowski; Carmen Santiuste de Pablos; Viera Spustová; Gültekin Süleymanlar; Karlijn Van Stralen; Nestor Thereska; Christoph Wanner; Kitty J Jager
Journal:  Clin Kidney J       Date:  2015-03-23

10.  Analysis of factors predicting mortality of new patients commencing renal replacement therapy 10 years of follow-up.

Authors:  Oliver T Browne; Victoria Allgar; Sunil Bhandari
Journal:  BMC Nephrol       Date:  2014-01-20       Impact factor: 2.388

View more
  4 in total

1.  Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests.

Authors:  Leili Tapak; Vida Sheikh; Ensiyeh Jenabi; Salman Khazaei
Journal:  J Prev Med Hyg       Date:  2020-10-06

2.  Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort.

Authors:  Emily de Souza Ferreira; Tiago Ricardo Moreira; Rodrigo Gomes da Silva; Glauce Dias da Costa; Luciana Saraiva da Silva; Samantha Bicalho de Oliveira Cavalier; Beatriz Oliveira Silva; Heloísa Helena Dias; Luiza Delazari Borges; Juliana Costa Machado; Rosângela Minardi Mitre Cotta
Journal:  BMC Nephrol       Date:  2020-11-23       Impact factor: 2.388

3.  Bloodstream infection at hemodialysis facilities in Jeddah: a medical record review.

Authors:  Shaima Muhammed Alhazmi; Samah Omar Noor; Majid Mousa Alshamrani; Fayssal Mostafa Farahat
Journal:  Ann Saudi Med       Date:  2019-08-05       Impact factor: 1.526

4.  Survival Percentile and Predictors of Difference in Survival among Hemodialysis Patients and Their Additive Interaction Using Laplace Regression.

Authors:  Salman Khazaei; Mehdi Yaseri; Vida Sheikh; Maryam Nazemipour; Ebrahim Hazrati; Mohammad Ali Mansournia
Journal:  J Res Health Sci       Date:  2020-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.